{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:09:40Z","timestamp":1794535780559,"version":"4.9.1"},"reference-count":33,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2016,7,27]]},"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Historically, the survival of patients with von Hippel-Lindau disease (vHL) has been poorer than that of the general population. We aimed to determine whether the survival of <jats:italic>VHL<\/jats:italic> mutation carriers and their risk of vHL-related death has changed over time and how it has been affected by sex, genotype and surveillance attendance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In a retrospective cohort study, we included all known Danish vHL families with a <jats:italic>VHL<\/jats:italic> mutation. We assessed the survival and causes of death for 143 <jats:italic>VHL<\/jats:italic> mutation carriers using Cox regression models and compared vHL survival with that of 137 siblings without vHL. vHL life expectancy was compared with the general population using a relative survival model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The estimated mean life expectancies for male and female patients born in 2000 were 67 and 60\u2005years, respectively. Survival is influenced by the sex and genotype of the patient. Female patients have a significantly higher risk of vHL-related death than male patients (HR=2.25, 95% CI 1.20 to 4.20, p=0.011). Overall, 79% (53 of 67) of deaths were vHL-related, but the risk of vHL-related death has decreased over time, as has the frequency of renal cell carcinoma (RCC)-related death. Surveillance is especially beneficial for truncating mutation carriers, who have the greatest RCC and central nervous system (CNS) hemangioblastoma risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>vHL survival has improved over time and has become closer to that of siblings without vHL and the general population. Even though the risk of vHL-related death has decreased significantly, the main cause of death is still CNS hemangioblastomas and hence improved treatment options are essential.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmedgenet-2016-104058","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T22:39:12Z","timestamp":1471559952000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":101,"title":["Survival and causes of death in patients with von Hippel-Lindau disease"],"prefix":"10.1136","volume":"54","author":[{"given":"Marie Louise M\u00f8lgaard","family":"Binderup","sequence":"first","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette M\u00f8ller","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Clinic of Cognitive Therapy, Mental Health Center Sct. Hans, Capital Region of Denmark, Roskilde, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben","family":"Budtz-J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Biostatistics, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Luise","family":"Bisgaard","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,8,18]]},"reference":[{"key":"2025100521470483000_54.1.11.1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2010.175"},{"key":"2025100521470483000_54.1.11.2","first-page":"521","article-title":"Genetic analysis of von Hippel-Lindau disease","volume":"31","author":"Nordstrom-O'Brien","year":"2010","journal-title":"Hum Mutat"},{"key":"2025100521470483000_54.1.11.3","first-page":"B4763","article-title":"Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition","volume":"60","author":"Binderup","year":"2013","journal-title":"Dan Med J"},{"key":"2025100521470483000_54.1.11.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.6140"},{"key":"2025100521470483000_54.1.11.5","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/77.2.1151"},{"key":"2025100521470483000_54.1.11.6","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.8.508"},{"key":"2025100521470483000_54.1.11.7","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0415"},{"key":"2025100521470483000_54.1.11.8","doi-asserted-by":"publisher","DOI":"10.3171\/2014.1.JNS131431"},{"key":"2025100521470483000_54.1.11.9","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2011-100562"},{"key":"2025100521470483000_54.1.11.10","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.33.2.120"},{"key":"2025100521470483000_54.1.11.11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1998.00337.x"},{"key":"2025100521470483000_54.1.11.12","doi-asserted-by":"publisher","DOI":"10.1007\/s007010050412"},{"key":"2025100521470483000_54.1.11.13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.10.898"},{"key":"2025100521470483000_54.1.11.14","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.44"},{"key":"2025100521470483000_54.1.11.15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002064"},{"key":"2025100521470483000_54.1.11.16","doi-asserted-by":"publisher","DOI":"10.3171\/2012.7.JNS12367"},{"key":"2025100521470483000_54.1.11.17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182661f3c"},{"key":"2025100521470483000_54.1.11.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2009.01281.x"},{"key":"2025100521470483000_54.1.11.19","first-page":"379","article-title":"Famili\u00e6r Angiomatosis retinae et cerebelli -Lindau's Sygdom","volume":"92","author":"Moller","year":"1930","journal-title":"Ugeskrift for laeger"},{"key":"2025100521470483000_54.1.11.20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1755-3768.1952.tb07650.x","article-title":"Another family with von Hippel-Lindau's disease","volume":"30","author":"Moller","year":"1952","journal-title":"Acta Ophthalmologica"},{"key":"2025100521470483000_54.1.11.21","unstructured":"Mortality data for the population of Denmark. http:\/\/www.mortality.org\/cgi-bin\/hmd\/country.php?cntr=DNK&level=1 (accessed 4-5-2016)."},{"key":"2025100521470483000_54.1.11.22","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1597"},{"key":"2025100521470483000_54.1.11.23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2350-13-54","article-title":"Identification of 3 novel VHL germ-line mutations in Danish VHL patients","volume":"13","author":"Dandanell","year":"2012","journal-title":"BMC Med Genet"},{"key":"2025100521470483000_54.1.11.24","doi-asserted-by":"crossref","unstructured":"Decker J , Neuhaus C , MacDonald F , Brauch H , Maher ER . Clinical utility gene card for: von Hippel-Lindau (VHL). Eur J Hum Genet 2014;22. doi:10.1038\/ejhg.2013.180","DOI":"10.1038\/ejhg.2013.180"},{"key":"2025100521470483000_54.1.11.25","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov313"},{"key":"2025100521470483000_54.1.11.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140257"},{"key":"2025100521470483000_54.1.11.27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71048"},{"key":"2025100521470483000_54.1.11.28","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1891"},{"key":"2025100521470483000_54.1.11.29","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000092780.85876.de"},{"key":"2025100521470483000_54.1.11.30","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20082"},{"key":"2025100521470483000_54.1.11.31","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20385"},{"key":"2025100521470483000_54.1.11.32","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A"},{"key":"2025100521470483000_54.1.11.33","unstructured":"Andersen MK , Bisgaard ML , Brandt C , Friis-Hansen L , Gerdes AM , Harbud V , Kj\u00e6rgaard S , Kosteljanetz M , Rosenberg T , Schwartz M , Sunde L . Von Hippel-Lindaus Reference Program vedr. Udredning og Kontrol, version 2.0. Ugeskr Laeger 2005."}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2016-104058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T04:47:13Z","timestamp":1759726033000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2016-104058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,14]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1136\/jmedgenet-2016-104058"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2016-104058","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,18]]}}}